-
A project that started out as a response to post-9/11 bioterrorism fears is turning out to have much more practical everyday applications, say two ED managers who have pioneered the use of a system that monitors for unusual patterns or patient surges. While still valuable for detecting terrorist attacks, the system can reveal more mundane but useful information in any ED, they say.
-
The EDs at St. Charles Mercy in Oregon, OH, and St. Anne Mercy in Toledo have adopted a streamlined triage system to shorten waiting times, and managers report that it has been very effective without compromising patient safety.
-
While youre waiting for three physicians to return your calls about their patients in your ED, you anxiously watch the clock and realize that if they dont call before leaving the office, they arent likely to call until tomorrow. Dont you have enough to worry about without trying to track down dozens of physicians all the time?
-
Here are the 15 Nursing-Sensitive Performance Measures endorsed by the Washington, DC-based National Quality Forum.
-
Do nurses at your facility complain they are overworked and understaffed? If so, you may have a bigger problem than retention on your hands compelling new evidence suggests poor nursing conditions put patients in danger.
-
If you still are doing last-minute ramp-up preparation for Joint Commission on Accreditation of Healthcare Organizations surveys, youre going to have big problems with the Shared Visions New Pathways process, warns Lynne Adams, CPHQ, director of quality at Upper Chesapeake Medical Center in Bel Air, MD.
-
Theres no denying that paying close attention to performance measures can improve patient safety at your organization, but heres another powerful motivator: Your core measure data will have a wider audience this summer when the Joint Commission on Accreditation of Healthcare Organizations begins making its Quality Reports publicly available.
-
New HIV epidemics in Eastern Europe, Central Asia, and China are spreading fast due to injection drug use (IDU) transmission, and these epidemics will continue to escalate unless the United Nations and individual countries make major policy changes, a new report charges.
-
Bristol-Myers Squibb Co. (BMS) of Princeton, NJ, recently showed through concept data that an attachment inhibitor BMS-488043 can have potent antiviral activity in HIV-1-infected patients.
-
While pharmaceutical companies and investigators work for a medication solution to the lipodystrophy and other metabolic disorders that plague some HIV patients, other research is looking into nonmedical solutions, such as vitamin use and exercise.
